CRBU Financial Statements

Balance sheet, income statement, cash flow, and dividends for Caribou Biosciences Inc (CRBU).


$143.98M Market Cap.

As of 03/10/2025 5:00 PM ET (MRY) • Disclaimer

CRBU Market Cap. (MRY)


CRBU Shares Outstanding (MRY)


CRBU Assets (MRY)


Total Assets

$313.31M

Total Liabilities

$60.36M

Total Investments

$242.37M

CRBU Income (MRY)


Revenue

$9.99M

Net Income

-$149.10M

Operating Expense

$176.61M

CRBU Cash Flow (MRY)


CF Operations

-$138.20M

CF Investing

$86.61M

CF Financing

$16.72M

CRBU Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

-

-

0%

-

CRBU Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$313,313,000 (-27.51%)

$432,209,000 (15.64%)

$373,765,000 (-15.51%)

$442,356,000 (1127.20%)

Assets Current

$219,377,000 (-35.26%)

$338,841,000 (30.20%)

$260,248,000 (-33.47%)

$391,192,000 (1509.45%)

Assets Non-Current

$93,936,000 (0.61%)

$93,368,000 (-17.75%)

$113,517,000 (121.87%)

$51,164,000 (335.81%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$252,951,000 (-31.34%)

$368,401,000 (22.44%)

$300,871,000 (-22.42%)

$387,825,000 (1754.76%)

Property Plant & Equipment Net

$39,290,000 (-2.87%)

$40,452,000 (15.88%)

$34,908,000 (614.30%)

$4,887,000 (39.55%)

Cash & Equivalents

$16,293,000 (-68.15%)

$51,162,000 (-12.30%)

$58,338,000 (-75.73%)

$240,420,000 (1407.05%)

Accumulated Other Comprehensive Income

$255,000 (750.00%)

$30,000 (101.98%)

-$1,518,000 (-1024.44%)

-$135,000 (0%)

Deferred Revenue

$6,446,000 (-27.97%)

$8,949,000 (-65.44%)

$25,891,000 (-15.76%)

$30,735,000 (2699.18%)

Total Investments

$242,369,000 (-26.33%)

$328,995,000 (23.50%)

$266,396,000 (47.41%)

$180,714,000 (2269.71%)

Investments Current

$193,244,000 (-30.40%)

$277,665,000 (46.66%)

$189,325,000 (39.81%)

$135,412,000 (0%)

Investments Non-Current

$49,125,000 (-4.30%)

$51,330,000 (-33.40%)

$77,071,000 (70.13%)

$45,302,000 (494.05%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$2,093,000 (-14.01%)

$2,434,000 (0.70%)

$2,417,000 (-63.58%)

$6,636,000 (28.60%)

Trade & Non-Trade Payables

$2,476,000 (-20.64%)

$3,120,000 (172.25%)

$1,146,000 (-71.28%)

$3,990,000 (53.40%)

Accumulated Retained Earnings (Deficit)

-$448,390,000 (-49.82%)

-$299,285,000 (-51.76%)

-$197,215,000 (-101.66%)

-$97,794,000 (-216.78%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$548,000 (-1.62%)

$557,000 (46.19%)

$381,000 (-19.96%)

$476,000 (207.10%)

Total Debt

$26,487,000 (-2.29%)

$27,108,000 (-2.30%)

$27,746,000 (0%)

$0 (0%)

Debt Current

$1,426,000 (18.83%)

$1,200,000 (24.22%)

$966,000 (0%)

$0 (0%)

Debt Non-Current

$25,061,000 (-3.27%)

$25,908,000 (-3.26%)

$26,780,000 (0%)

$0 (0%)

Total Liabilities

$60,362,000 (-5.40%)

$63,808,000 (-12.46%)

$72,894,000 (33.67%)

$54,531,000 (200.28%)

Liabilities Current

$30,651,000 (8.30%)

$28,302,000 (0.62%)

$28,128,000 (8.90%)

$25,829,000 (108.48%)

Liabilities Non-Current

$29,711,000 (-16.32%)

$35,506,000 (-20.69%)

$44,766,000 (55.97%)

$28,702,000 (397.35%)

CRBU Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$9,994,000 (-71.01%)

$34,477,000 (148.91%)

$13,851,000 (44.31%)

$9,598,000 (-22.35%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$46,457,000 (20.79%)

$38,461,000 (1.16%)

$38,020,000 (56.32%)

$24,322,000 (72.99%)

Research & Development Expense

$130,153,000 (16.13%)

$112,075,000 (36.29%)

$82,230,000 (57.36%)

$52,255,000 (51.79%)

Operating Expenses

$176,610,000 (17.32%)

$150,536,000 (25.19%)

$120,250,000 (57.03%)

$76,577,000 (57.94%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

-$9,000 (-104.66%)

$193,000 (175.71%)

$70,000 (-78.19%)

$321,000 (117.65%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$149,105,000 (-46.08%)

-$102,070,000 (-2.66%)

-$99,421,000 (-48.56%)

-$66,923,000 (-95.07%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$149,105,000 (-46.08%)

-$102,070,000 (-2.66%)

-$99,421,000 (-48.56%)

-$66,923,000 (-95.07%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$149,105,000 (-46.08%)

-$102,070,000 (-2.66%)

-$99,421,000 (-48.56%)

-$66,923,000 (-95.07%)

Weighted Average Shares

$90,317,925 (22.37%)

$73,807,597 (21.39%)

$60,801,133 (92.02%)

$31,663,243 (270.47%)

Weighted Average Shares Diluted

$90,317,925 (22.37%)

$73,807,597 (21.39%)

$60,801,133 (92.02%)

$31,663,243 (270.47%)

Earning Before Interest & Taxes (EBIT)

-$149,114,000 (-46.37%)

-$101,877,000 (-2.54%)

-$99,351,000 (-49.17%)

-$66,602,000 (-84.46%)

Gross Profit

$9,994,000 (-71.01%)

$34,477,000 (148.91%)

$13,851,000 (44.31%)

$9,598,000 (-22.35%)

Operating Income

-$166,616,000 (-43.56%)

-$116,059,000 (-9.08%)

-$106,399,000 (-58.85%)

-$66,979,000 (-85.41%)

CRBU Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$86,607,000 (227.02%)

-$68,183,000 (26.88%)

-$93,249,000 (47.14%)

-$176,397,000 (-2872.23%)

Net Cash Flow from Financing

$16,724,000 (-89.16%)

$154,298,000 (7133.85%)

$2,133,000 (-99.51%)

$433,429,000 (24881.50%)

Net Cash Flow from Operations

-$138,200,000 (-48.14%)

-$93,291,000 (-2.56%)

-$90,966,000 (-179.73%)

-$32,519,000 (2.10%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$34,869,000 (-385.91%)

-$7,176,000 (96.06%)

-$182,082,000 (-181.10%)

$224,513,000 (993.87%)

Net Cash Flow - Business Acquisitions and Disposals

-$1,625,000 (0%)

$0 (0%)

-$600,000 (40.00%)

-$1,000,000 (-0.20%)

Net Cash Flow - Investment Acquisitions and Disposals

$93,099,000 (264.57%)

-$56,570,000 (34.37%)

-$86,195,000 (50.26%)

-$173,276,000 (-2359.73%)

Capital Expenditure

-$4,867,000 (58.09%)

-$11,613,000 (-79.93%)

-$6,454,000 (-204.29%)

-$2,121,000 (-590.88%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

$1,031,000 (-29.62%)

Issuance (Purchase) of Equity Shares

$16,724,000 (-89.16%)

$154,298,000 (7133.85%)

$2,133,000 (-99.34%)

$323,571,000 (119741.11%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$16,706,000 (21.50%)

$13,750,000 (17.36%)

$11,716,000 (239.69%)

$3,449,000 (244.21%)

Depreciation Amortization & Accretion

$6,100,000 (9.46%)

$5,573,000 (53.06%)

$3,641,000 (270.02%)

$984,000 (9.33%)

CRBU Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-1491.90% (-403.85%)

-296.10% (58.75%)

-717.80% (-2.94%)

-697.30% (-151.19%)

EBITDA Margin

-1431.00% (-412.35%)

-279.30% (59.58%)

-691.00% (-1.07%)

-683.70% (-140.06%)

Return on Average Equity (ROAE)

-50.20% (-61.41%)

-31.10% (-5.07%)

-29.60% (21.69%)

-37.80% (-108.80%)

Return on Average Assets (ROAA)

-41.50% (-61.48%)

-25.70% (-6.20%)

-24.20% (-11.01%)

-21.80% (68.86%)

Return on Sales (ROS)

-1492.00% (-404.91%)

-295.50% (58.80%)

-717.30% (-3.37%)

-693.90% (-137.56%)

Return on Invested Capital (ROIC)

-46.40% (-48.72%)

-31.20% (2.80%)

-32.10% (78.21%)

-147.30% (59.07%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0%

Price to Earnings Ratio (P/E)

-0.96 (76.78%)

-4.15 (-8.44%)

-3.83 (46.46%)

-7.15

Price to Sales Ratio (P/S)

14.37 (17.14%)

12.27 (-55.50%)

27.57 (-44.62%)

49.78

Price to Book Ratio (P/B)

0.57 (-58.62%)

1.38 (8.01%)

1.27 (-45.64%)

2.34

Debt to Equity Ratio (D/E)

0.24 (38.15%)

0.17 (-28.51%)

0.24 (71.63%)

0.14 (118.19%)

Earnings Per Share (EPS)

-1.65 (-19.57%)

-1.38 (15.85%)

-1.64 (22.27%)

-2.11 (47.38%)

Sales Per Share (SPS)

0.11 (-76.23%)

0.47 (104.82%)

0.23 (-24.75%)

0.3 (-79.05%)

Free Cash Flow Per Share (FCFPS)

-1.58 (-11.47%)

-1.42 (11.30%)

-1.6 (-46.44%)

-1.09 (72.11%)

Book Value Per Share (BVPS)

2.8 (-43.88%)

4.99 (0.87%)

4.95 (-59.60%)

12.25 (546.68%)

Tangible Assets Book Value Per Share (TABVPS)

3.47 (-40.76%)

5.86 (-4.73%)

6.15 (-56.00%)

13.97 (231.22%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (75.00%)

-4 (-33.33%)

-3 (57.14%)

-7

Enterprise Value Over EBITDA (EV/EBITDA)

-0.97 (78.30%)

-4.47 (-29.98%)

-3.44 (52.33%)

-7.21

Asset Turnover

0.03 (-67.82%)

0.09 (155.88%)

0.03 (9.68%)

0.03 (-87.70%)

Current Ratio

7.16 (-40.22%)

11.97 (29.40%)

9.25 (-38.91%)

15.14 (671.92%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$143,067,000 (-36.38%)

-$104,904,000 (-7.68%)

-$97,420,000 (-181.24%)

-$34,640,000 (-3.34%)

Enterprise Value (EV)

$138,649,772 (-67.76%)

$430,107,409 (30.78%)

$328,874,803 (-30.47%)

$472,988,200

Earnings Before Tax (EBT)

-$149,114,000 (-46.37%)

-$101,877,000 (-2.54%)

-$99,351,000 (-49.17%)

-$66,602,000 (-84.36%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$143,014,000 (-48.50%)

-$96,304,000 (-0.62%)

-$95,710,000 (-45.86%)

-$65,618,000 (-86.38%)

Invested Capital

$292,856,000 (-22.90%)

$379,853,000 (20.57%)

$315,045,000 (78.89%)

$176,107,000 (1797.30%)

Working Capital

$188,726,000 (-39.23%)

$310,539,000 (33.78%)

$232,120,000 (-36.47%)

$365,363,000 (2965.90%)

Tangible Asset Value

$313,313,000 (-27.51%)

$432,209,000 (15.64%)

$373,765,000 (-15.51%)

$442,356,000 (1127.20%)

Market Capitalization

$143,978,772 (-71.59%)

$506,710,409 (32.27%)

$383,089,803 (-57.82%)

$908,298,200

Average Equity

$296,976,750 (-9.62%)

$328,599,750 (-2.25%)

$336,167,750 (89.70%)

$177,211,500 (2318.75%)

Average Assets

$359,352,500 (-9.42%)

$396,709,750 (-3.24%)

$409,988,000 (33.26%)

$307,669,500 (528.03%)

Invested Capital Average

$321,545,750 (-1.63%)

$326,888,000 (5.54%)

$309,733,750 (584.96%)

$45,219,250 (350.68%)

Shares

90,552,687 (2.40%)

88,431,136 (44.97%)

61,001,561 (1.34%)

60,192,061 (17.54%)